Patient P-02080
Synthetic patientMETA-24 · Day 175 · 35–44 · M · baseline S11Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
11%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S11
- Day 10 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 10.
Primary contributors, last 14 days
- Toxicity-9
- GI instability-5
- Inflammatory activity-4
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable51 min
improving · +8.4 vs previous 14 d
Sleep duration
Wearable7.3 h
stable · -0.1 vs previous 14 d
Energy level
Daily log6.4/10
improving · +0.3 vs previous 14 d
Steps
Wearable5,570
improving · +519 vs previous 14 d
GI burden
Companion14.3/100
improving · -3.2 vs previous 14 d
Adherence
Companion90.8 %
stable · +1.4 vs previous 14 d
Sleep quality
Wearable56.3/100
stable · -1.5 vs previous 14 d
Glucose, CGM daily mean
CGM125 mg/dL
stable · +0.9 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 78 from the failing basin, 20 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Protein (supports)perturbation · steering +6.3
- Daily walks resumedperturbation · steering +3.3
- Proteinsupporter · GI -3.2 next day
Main detractors to watch
- Rapid metabolizerhidden · steering -8
- Antibiotic courseperturbation · steering -4.7
- Poor-sleep weekperturbation · steering -3
- Low-HRV stretchperturbation · steering -2.7
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.2supporter · 95%
- Dietary fat load-1.1no signal · 34%
- Alcohol+0.8no signal · 25%
- Histamine load+0.5no signal · 15%
- Ultra-processed food-0.3no signal · 15%
- Caffeine-0.2no signal · 15%
- Simple carbohydrates+0.1no signal · 15%
- Insoluble fibre+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
- CYP2D6 Rapid metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
Microbiome
Shannon diversity 3.2 · butyrate capacity 57/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 57 ms
- Sleep
- 7.5 h
- Steps
- 4,590
- Resting HR
- 70 bpm
Daily log: GI score 14, nutritional resilience 65, adherence 91.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.